Samuel Agus

Israel board certified neurologist, Working with the industry since 2002. CMO at Byophytis. Biophytis SA, founded in 2006, develops drug candidates targeting diseases of aging. Using its technology and know-how, Biophytis has begun clinical development of innovative therapeutics to restore the muscular and visual functions in diseases with significant unmet medical needs.